C-MIC system follow-up visits study
Part of Heart & circulation clinical trials.
This study checks on people who previously received a C-MIC System, usually by asking them to come in for follow-up visits. It helps the team learn how the system is doing over time and supports better care planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously received the C-MIC System as part of the earlier C-MIC-II study
- You can sign a consent form in writing to join this study
- You are willing and able to attend the scheduled study visits
- You are not considered a “vulnerable patient” under the study’s rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows patients who have or will get a CCM device to see how well it works and how safe it is over time. It helps doctors learn more about improving heart function in people with heart failure.
This study checks how well specific MicroPort CRM heart devices and leads work in real life over time. If you already have one of these FDA/market-approved implants and can be followed yearly, the study helps the company monitor safety and performance.
This study tests a therapy called Cardiac Contractility Modulation (CCM) for people with heart failure. It uses a device to help the heart pump more strongly, and researchers compare it to standard care using patient records.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
Hear when a new Systolic Left Ventricular Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.